Yu Luo Tong

Quick links

Choose a section

Quick links to important sections

Advertisements

Yu Luo Tong

Advertisements
Advertisements

Method of action: Antihypertensive

Treatment option: Hypertension, Angina Pectoris

Advertisements

Overview of Yu Luo Tong

Quick Facts

Property Description
Active Ingredient Nicardipine hydrochloride
Form Capsules (Oral) and Solution (Intravenous)
Pharmacological Class Calcium Channel Blocker (Dihydropyridine)
General Purpose Lowering high blood pressure
Origin Synthetic organic compound

Yu Luo Tong: Identity, Type, and Composition

Yu Luo Tong is the trade name for a prescription-only medication that contains the synthetic compound nicardipine hydrochloride as its single active ingredient. This substance is chemically recognized as a dihydropyridine derivative.

As a single-active ingredient product, the drug is focused entirely on the specific pharmacological mechanism of nicardipine. Nicardipine's structure places it in the second-generation of its class, a factor often associated with favorable pharmacokinetic profiles.


Pharmacological Class and Available Forms

The medication belongs to the therapeutic and pharmacological class known as Calcium Channel Blockers (CCBs). Yu Luo Tong is available in several dosage forms, including oral capsules (such as extended-release capsules) and specialized intravenous formulations.

Nicardipine is clinically recognized for its high degree of vascular selectivity, meaning it primarily targets the smooth muscle cells in blood vessels. This action profile is a key distinguishing feature within the CCB class. The dual availability (oral and intravenous) allows healthcare providers utility for both chronic management and controlled, acute clinical intervention.


General Purpose: How Nicardipine Affects the Body

The primary general purpose of the nicardipine in Yu Luo Tong is to achieve a controlled and potent hypotensive effect through peripheral arterial vasodilation. It achieves this by selectively inhibiting the flow of calcium ions into the smooth muscle of artery walls, causing them to relax and widen.

This relaxation reduces the systemic vascular resistance (SVR) against which the heart pumps. Nicardipine is effective in managing elevated blood pressure, which is its fundamental therapeutic benefit.

Regulatory References

  1. LiverTox Nicardipine Monograph
Advertisements

What side effects are possible with Yu Luo Tong?

Possible side effects and safety information

The official regulatory safety profile for Yu Luo Tong (Nicardipine hydrochloride) is largely defined by adverse reactions stemming from its primary action as a potent peripheral vasodilator. Safety classifications are based on formal incidence data from clinical studies, often reported by regulatory bodies such as the FDA and EMA.

Officially Documented Adverse Reactions

The most Common adverse reactions reported in official labeling are typically headache, hypotension (low blood pressure), tachycardia (increased heart rate), and flushing (feeling of warmth or redness). Other frequently reported systemic effects include nausea/vomiting and peripheral edema (swelling in the legs and ankles).

Reactions involving specific organ systems include dizziness and somnolence (nervous system), dyspepsia and dry mouth (gastrointestinal system), and nocturia (urinary system).

Serious Adverse Events and Constraints

A clinically significant pattern documented in regulatory texts is the potential for exacerbation of angina, meaning an increase in the frequency, duration, or severity of chest pain, which has been observed with chronic oral therapy or when the dosage is increased.

The medicine is contraindicated in patients with advanced aortic stenosis due to the risk of worsening myocardial oxygen balance. Official labeling also mandates caution and close monitoring in patients with impaired hepatic function and impaired renal function due to alterations in drug clearance, as well as in patients with congestive heart failure. Furthermore, systemic hypotension should be avoided in patients who have sustained an acute cerebral infarction or hemorrhage.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes overdose of Yu Luo Tong (Nicardipine) as a condition requiring immediate emergency medical attention. Overdose manifestations are primarily cardiovascular, reflecting the drug's potent action.

Documented Manifestations and Actions

Classification Regulatory Statement
Documented Symptoms Overdose may present with profound systemic hypotension, bradycardia, initial tachycardia, and progressive atrioventricular (AV) conduction block. Neurological effects such as confusion, agitation, and delirium are also documented.
Severe Outcomes The risk of profound shock is noted. Management addresses life-threatening effects, which may include the risk of multiple organ failure in severe cases.
Required Action Seek medical help right away if an overdose is suspected. Contacting a health care provider or Poison Control is mandated immediately following potential overdose.

Supportive Management and Monitoring

Management is strictly symptomatic and supportive, as no specific antidote is officially documented. Continuous monitoring of cardiac and respiratory functions is required. Essential procedures include frequent blood pressure determinations and the use of vasopressors to manage severe hypotension. Intravenous calcium gluconate may be employed to help reverse some effects of calcium channel blockade. Population-specific notes warn of an increased risk of serious hypotension in the elderly and in patients with renal or hepatic impairment.

Advertisements

Therapeutic Uses of Yu Luo Tong

What Yu Luo Tong Treats: Main Uses and Benefits

Yu Luo Tong (Nicardipine) is generally applied across critical and chronic cardiovascular therapeutic domains to support the management of high arterial pressure and related symptoms, and is relevant for supportive and symptomatic relief. This medication is relevant in contexts involving heightened systemic burden, primarily for managing severe hypertension (acute and chronic), and easing symptoms of chronic stable angina pectoris.

This medication is applied across therapeutic domains where additional symptomatic support is needed to manage elevated arterial pressure and related cardiac symptoms. This therapeutic approach helps patients cope more steadily with symptom fluctuations and supports general well-being. It is applied in clinical settings that involve acute or unstable symptom patterns where supportive symptom management is appropriate.


Quick Summary of Therapeutic Use

Yu Luo Tong assists with the long-term management of essential hypertension and contributes to improved comfort during periods of heightened symptoms related to angina. Its use is relevant for easing the symptoms of chest pain and is applied in addressing symptoms related to acute or episodic changes in pressure.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Usage Restrictions

Yu Luo Tong (nicardipine) is officially indicated for adult patients (18 years and older) under standard labeled conditions. Eligibility is defined by the following strict rules based on regulatory labeling:


Classification Population/Condition
Contraindicated Advanced aortic stenosis; known hypersensitivity to the drug or its components.
IV Contraindicated Unstable angina; immediately following myocardial infarction.

Conditional Use (Requires Close Monitoring)

Patients with impaired hepatic or renal function require cautious use, slow dose titration, and close monitoring due to altered drug clearance. Caution is also advised for those with congestive heart failure or following an acute cerebral event.

Age and Reproductive Restrictions

The safety and efficacy of Yu Luo Tong have not been established in pediatric patients (under 18 years). In older adults, dose selection should be cautious due to the higher frequency of decreased organ function. Use during pregnancy (FDA Category C) is only allowed if the potential benefit justifies the potential risk, and the oral formulation is generally not recommended while breastfeeding.

Advertisements

What should I know about interactions with other medicines?

Yu Luo Tong Interactions with other medicines and products

The official regulatory profile for Yu Luo Tong (Nicardipine) documents several forms of clinically significant interactions, primarily based on its ability to inhibit hepatic enzymes. This pharmacokinetic inhibition dictates a formal increased exposure risk for co-administered medicinal products.

Documented Interaction Patterns

  • Exposure-Altering Interactions: Nicardipine is a documented inhibitor of multiple CYP enzymes (CYP3A4, 2D6, 2C8, 2C19), which increases the plasma levels of co-administered Cyclosporine and Tacrolimus. The regulatory label also states that Cimetidine increases the plasma concentration of Nicardipine itself.
  • Pharmacodynamic Effects: Co-administration with Beta-Blockers requires caution due to a potential for an additive negative effect on myocardial contractility. A combination of a calcium channel blocker, a beta-blocker, and Fentanyl anesthesia has been associated with reports of severe hypotension. Alcohol (Ethanol) may contribute an additive effect to blood pressure lowering.
  • Administration Restrictions: The intravenous formulation is formally incompatible and must not be combined in the same line with Sodium Bicarbonate (5%) Injection or Lactated Ringer's Injection.
  • Food and Timing Rules: The extended-release capsules must be taken with food, yet consumption of a high-fat meal is documented to reduce Nicardipine's total absorption. Grapefruit Juice is explicitly listed as a substance that can significantly increase the drug's systemic exposure.
  • Population Note: In patients with impaired hepatic function, Nicardipine’s reduced clearance leads to increased plasma levels, potentially magnifying the significance of drug-drug interactions.
Advertisements

Mechanism of Action

How Yu Luo Tong Works

Yu Luo Tong (nicardipine) is a substance that modulates vascular tone through a precise, multi-step pharmacodynamic mechanism focusing on calcium ion regulation.


Blocking L-Type Calcium Channels in Arteries

The drug's primary function is to physically inhibit the Voltage-dependent L-type Calcium Channels ( Ca v1.2) located on the membrane of vascular smooth muscle cells. By binding to a site on these channels, nicardipine prevents the influx of extracellular calcium ions ( Ca^2+) into the cell cytoplasm. This molecular action is selective for the vascular system, targeting arteries over cardiac tissue.


Mechanistic Cascade to Reduce Systemic Resistance

The lack of intracellular Ca^2+ disrupts the excitation-contraction coupling pathway, meaning the smooth muscle cannot contract and instead relaxes, causing widespread arterial vasodilation. This physiological consequence leads to a reduction in Systemic Vascular Resistance (SVR)—the resistance the heart must overcome to pump blood. The reduced SVR is the resulting systemic change that influences arterial pressure.


Physiological Constraint: Reflex Sympathetic Action

The mechanism of rapid SVR reduction can trigger a compensatory response via the baroreceptor reflex. This is a functional limitation where the body’s sympathetic nervous system activates to counter the pressure drop, potentially resulting in a secondary increase in heart rate (Reflex Tachycardia), which acts as a counter-regulatory mechanism.

Advertisements

Dosage and Administration Information

How to Use Yu Luo Tong

Yu Luo Tong (nicardipine) is administered via two distinct routes, determined by the goal of treatment: oral capsules for chronic, long-term management and intravenous (IV) continuous infusion for acute, controlled intervention in critical care settings. The administration protocol adheres to established specifications.


Official Administration Schedules

Administration Parameter Oral Capsule Regimen IV Infusion Regimen
Starting Dose Immediate-release: 20 mg three times daily (TID). Sustained-release: 30 mg twice daily (BID). 5 mg per hour continuous infusion.
Adjustment Interval Dosing adjustments occur no more frequently than every three days to reach a steady maintenance level. Titration increments (e.g., 2.5 mg/hour) occur at short, frequent intervals (e.g., every 5 to 15 minutes).
Maximum Dose 120 mg total daily dose (immediate-release). 15 mg per hour continuous infusion rate.

Procedural and Population Requirements

Intravenous administration requires the concentrated solution to be diluted to 0.1 mg/mL with compatible fluids, such as normal saline, prior to continuous infusion. Furthermore, the IV infusion site must be changed at least every 12 hours.

When transitioning from IV to oral use, the initial dose of the oral capsule is administered one hour prior to discontinuing the continuous IV infusion. For specific populations, caution is indicated: patients with hepatic impairment should start with a lower oral dose (e.g., 20 mg twice daily), and older adults should generally be started at the lower end of the adult dosing range.

Advertisements

Recent Clinical Evidence

Yu Luo Tong: Recent Clinical Evidence

The formulation known as Yu Luo Tong, or similar herbal formulas such as Luo Tong Formula (LTF) and Tong-luo Qu-tong Plaster, has been the subject of research focused primarily on conditions associated with impaired circulation and chronic inflammation, particularly within the domain of Traditional Chinese Medicine (TCM).

Efficacy Studies

Clinical and preclinical research has explored the use of these formulations in several areas:

  • Diabetic Retinopathy (DR): Studies using animal models investigated the use of Luo Tong Formula (LTF) to moderate vascular leakage and histological changes in the retina associated with diabetes. Researchers suggested that an observed benefit may be linked to modulation of vascular repair and specific molecular pathways.
  • Chronic Musculoskeletal Pain: Preclinical studies, often involving plaster formulations, examined whether they were associated with changes in measures of muscle pain. Findings focused on associations with the reduction of inflammatory markers and gene expression related to inflammation.
  • Knee Osteoarthritis (KOA): Research protocols for multi-center, randomized trials have been developed to evaluate the safety and clinical outcomes of related plasters in managing joint pain and stiffness, with primary outcome measures typically including standardized pain and function scores.

Safety and Research Limitations

Safety data generally rely on the documentation of adverse events within the scope of these clinical trials and observational studies. It is important to note that many reports on these complex herbal formulations originate from preclinical (animal) models or smaller-scale studies. Robust, large-scale, placebo-controlled clinical trials, particularly those adhering to international standards, are often necessary to confirm observed associations and establish a clear risk-benefit profile in broader human populations.

Key Studies & References

  1. Study on efficacy and safety of Tong-luo Qu-tong plaster treatment for knee osteoarthritis: study protocol for a randomized, double-blind, parallel positive controlled, multi-center clinical trial (NCT03309501)
  2. Traditional Chinese Medicine - Evidence for TCM, Safety, and Limitations (MSD Manual Professional Edition)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Yu Luo Tong (FAQ)


Q: Is it possible to take Yu Luo Tong for a long time?

A: The oral form of the medication is specifically indicated in official regulatory documents for the chronic, long-term management of conditions like high blood pressure and angina pectoris. The decision for continuous use is typically determined during patient assessment with the supervising prescriber.


Q: Is Yu Luo Tong considered a permanent treatment or temporary?

A: Yu Luo Tong (nicardipine) is most often described in its oral form for the chronic management of conditions such as hypertension. This approach generally involves continuous, regular use as part of long-term management, according to official product information.


Q: Does Yu Luo Tong have a generic version available?

A: The active ingredient, nicardipine hydrochloride, is associated with approved generic versions that are available in some regions, according to authoritative regulatory records. The availability of generic alternatives is often tracked by government regulatory bodies.


Q: How long does it usually take to feel the effects of Yu Luo Tong?

A: The time to effect depends on the formulation. Following oral administration, the drug's plasma levels are detectable in about 20 minutes, with maximal plasma concentration typically achieved between 1 and 4 hours after taking the capsule. The intravenous form has a very rapid onset of action.


Q: What happens when a person stops taking Yu Luo Tong suddenly?

A: The regulatory label notes that discontinuing the use of nicardipine should be done under the direction of a healthcare professional. In some patients, rapid dosage changes or abrupt discontinuation have been associated with a potential for an increase in the frequency, duration, or severity of angina (chest pain).


Q: What is the purpose of the different strengths of Yu Luo Tong tablets?

A: Different strengths (such as 20 mg and 30 mg) and formulations (immediate-release and extended-release) are available to enable healthcare providers to adjust the dose individually. This is done to achieve and maintain the targeted therapeutic effect for each patient.


Q: Is Yu Luo Tong an anti-inflammatory medicine?

A: The medication's primary and labeled function is as a calcium channel blocker (vasodilator), which works by relaxing blood vessels to lower blood pressure. While research has explored other effects, it is not officially classified or indicated as a typical anti-inflammatory drug.


Q: Are there specific populations where Yu Luo Tong is less effective?

A: Official documents note that the blood pressure-lowering effect may be less prominent in individuals who are normotensive (have normal blood pressure) compared to those who are hypertensive. Efficacy can also be altered in patients with impaired hepatic or renal function due to how the body clears the drug.


Q: Is there evidence for Yu Luo Tong's use in conditions other than the main one listed?

A: Research has investigated the use of the drug or related complex herbal formulations in other areas, such as diabetic retinopathy and chronic musculoskeletal pain. However, official indications relate only to its use as a calcium channel blocker for specified conditions.


Q: Is Yu Luo Tong safe for children and teenagers?

A: Official regulatory documents state that the safety and efficacy of the oral formulation of nicardipine have not been established in pediatric patients (individuals under 18 years).


Q: Does Yu Luo Tong make you feel tired or drowsy?

A: Yes, official product information lists adverse reactions related to the nervous system, which include common effects such as dizziness and somnolence (drowsiness).


Q: Can I take Yu Luo Tong if I have a history of stomach problems?

A: Official product information notes that nicardipine use has been associated with gastrointestinal adverse effects, such as nausea and dyspepsia (indigestion). Additionally, certain stomach acid-reducing medicines, like cimetidine, are known to increase the concentration of nicardipine in the blood.


Q: Can Yu Luo Tong be taken with common pain relievers?

A: Regulatory sources indicate that the blood pressure-lowering effect of nicardipine may be diminished when it is used alongside certain types of non-steroidal anti-inflammatory drugs (NSAIDs).


Q: Does alcohol consumption affect how Yu Luo Tong works?

A: The official regulatory profile indicates that consuming alcohol may contribute to an additive effect in lowering blood pressure when used concurrently with Yu Luo Tong.


Q: Does Yu Luo Tong affect how other chronic disease medications work?

A: Yes, official regulatory documents classify nicardipine as an inhibitor of several CYP enzymes. This means it can increase the plasma levels and potential exposure risk for numerous co-administered medicines, including cyclosporine, tacrolimus, and certain statins.


Q: Are there specific vitamins or supplements that interact with Yu Luo Tong?

A: The inhibition of CYP enzymes by nicardipine is a documented concern for interactions with other substances. This can lead to increased plasma concentrations of co-administered products, including ingredients found in certain vitamins and supplements.


Q: Can I use natural herbal remedies at the same time as Yu Luo Tong?

A: Given that nicardipine is known to affect metabolic enzymes (like CYP3A4), there is a possibility of interaction with various herbal remedies that are metabolized by the same enzymes. Such interactions could alter the concentration of either nicardipine or the herbal remedy in the bloodstream.


Q: What kinds of procedures or surgeries might require stopping Yu Luo Tong?

A: Official documents caution that the combination of nicardipine, a beta-blocker, and Fentanyl anesthesia has been associated with reports of severe hypotension (low blood pressure). The use of the drug requires careful consideration around any procedure that involves anesthesia or rapid blood pressure changes.


Q: What information should I provide my dentist if I take Yu Luo Tong?

A: Information provided to a dentist should include the use of nicardipine before any procedure. This is important due to the potential for significant hypotension (low blood pressure) when the drug is combined with certain anesthetics.


Q: Can Yu Luo Tong be split or crushed to make it easier to take?

A: The official labeling for the extended-release capsules instructs that the capsule should be swallowed whole. The medication should not be split, crushed, or chewed because doing so may alter the medication's intended release mechanism.


Q: Do studies support the long-term use of Yu Luo Tong?

A: Clinical studies and regulatory indications support the use of the oral form of nicardipine for long-term management of hypertension and angina. However, research into the complex herbal formulations related to the drug's name often focuses on specific, specialized conditions and may not directly apply to the primary active ingredient.

Advertisements

How should Yu Luo Tong be stored and disposed of?

The storage and disposal of Yu Luo Tong, which contains nicardipine hydrochloride, must strictly follow the official regulatory requirements to ensure product integrity.

Storage Requirements

Oral capsules must be stored at Controlled Room Temperature, typically between 20 C and 25 C (68 F and 77 F). The medication must be protected from excessive moisture and light and should be kept in its original, tightly closed container.

Intravenous solutions must be protected from freezing. All formulations must be stored out of the sight and reach of children.

Disposal

Unused or expired product must not be flushed down a toilet or poured into a drain. Disposal must comply with local and governmental regulations, such as utilizing drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Yu Luo Tong found in:

A-Z Index: